Cargando…
Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
Autores principales: | Otten, Antonius T, Bourgonje, Arno R, Visschedijk, Marijn C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721761/ https://www.ncbi.nlm.nih.gov/pubmed/36481042 http://dx.doi.org/10.1016/S2468-1253(22)00404-6 |
Ejemplares similares
-
SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021) -
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022) -
Moving towards more patient-centred clinical trials in IBD
por: Noor, Nurulamin M., et al.
Publicado: (2021) -
Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021) -
Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)